Bifidobacterium animalis was recently shown to suppress NSCLC progression via its metabolite 3-IAA, which modulates AhR–m6A/STAT3 signaling, reshapes macrophage, and boosts CD8+ T-cell function along the gut–lung axis [216]. The gene discussed is STAT3; the disease is non-small cell lung carcinoma.